506 related articles for article (PubMed ID: 16086652)
1. Echinocandins: role in antifungal therapy, 2005.
Zaas AK; Alexander BD
Expert Opin Pharmacother; 2005 Aug; 6(10):1657-68. PubMed ID: 16086652
[TBL] [Abstract][Full Text] [Related]
2. The echinocandins.
Cappelletty D; Eiselstein-McKitrick K
Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
[TBL] [Abstract][Full Text] [Related]
3. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Echinocandins in the management of invasive fungal infections, Part 2.
Morris MI; Villmann M
Am J Health Syst Pharm; 2006 Oct; 63(19):1813-20. PubMed ID: 16990627
[TBL] [Abstract][Full Text] [Related]
7. Emerging echinocandins for treatment of invasive fungal infections.
Turner MS; Drew RH; Perfect JR
Expert Opin Emerg Drugs; 2006 May; 11(2):231-50. PubMed ID: 16634699
[TBL] [Abstract][Full Text] [Related]
8. Caspofungin acetate for treatment of invasive fungal infections.
Pacetti SA; Gelone SP
Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
[TBL] [Abstract][Full Text] [Related]
9. A comparative evaluation of properties and clinical efficacy of the echinocandins.
Kim R; Khachikian D; Reboli AC
Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
[TBL] [Abstract][Full Text] [Related]
10. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
11. Role of micafungin in the antifungal armamentarium.
Ikeda F; Tanaka S; Ohki H; Matsumoto S; Maki K; Katashima M; Barrett D; Aoki Y
Curr Med Chem; 2007; 14(11):1263-75. PubMed ID: 17504145
[TBL] [Abstract][Full Text] [Related]
12. Anidulafungin: a novel echinocandin.
Vazquez JA; Sobel JD
Clin Infect Dis; 2006 Jul; 43(2):215-22. PubMed ID: 16779750
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
Groll AH; Walsh TJ
Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
[TBL] [Abstract][Full Text] [Related]
14. Management of invasive mycoses in hematology patients: current approaches.
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177
[TBL] [Abstract][Full Text] [Related]
15. [Systemic antifungals. Pharmacodynamics and pharmacokinetics].
Catalán M; Montejo JC
Rev Iberoam Micol; 2006 Mar; 23(1):39-49. PubMed ID: 16499430
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
Maschmeyer G; Glasmacher A
Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
[TBL] [Abstract][Full Text] [Related]
17. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
18. New options for the treatment of invasive fungal infections.
Rubin ZA; Somani J
Semin Oncol; 2004 Apr; 31(2 Suppl 4):91-8. PubMed ID: 15124141
[TBL] [Abstract][Full Text] [Related]
19. Echinocandin antifungals: review and update.
Morrison VA
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):325-42. PubMed ID: 16597212
[TBL] [Abstract][Full Text] [Related]
20. Anidulafungin: a new echinocandin with a novel profile.
Vazquez JA
Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
